Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
PHN-010 in Lung Cancer: NCT06457997 Clinical Landscape Report 2026
16 October 2026
NCT06457997 clinical landscape for Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Epcoritamab in High grade B-cell lymphoma: NCT06458439 Clinical Landscape Report 2026
16 October 2026
NCT06458439 clinical landscape for High grade B-cell lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pucotenlimab in Rhabdomyosarcoma: NCT06456892 Clinical Landscape Report 2026
16 October 2026
NCT06456892 clinical landscape for Rhabdomyosarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Telitacicept in Systemic Lupus Erythematosus: NCT06456567 Clinical Landscape Report 2026
16 October 2026
NCT06456567 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pasireotide Diaspartate in Desmoplastic Small Round Cell Tumor: NCT06456359 Clinical Landscape Report 2026
16 October 2026
NCT06456359 clinical landscape for Desmoplastic Small Round Cell Tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
Paclitaxel in Endometrial Endometrioid Adenocarcinoma: NCT06463028 Clinical Landscape Report 2026
16 October 2026
NCT06463028 clinical landscape for Endometrial Endometrioid Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
9 min read
IMPT-514 in Idiopathic Inflammatory Myopathies: NCT06462144 Clinical Landscape Report 2026
16 October 2026
NCT06462144 clinical landscape for Idiopathic Inflammatory Myopathies: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
Anti-CD19 CAR-NK cells(Second Affiliated Hospital, School of Medicine, Zhejiang University) in Mantle-Cell Lymphoma: NCT06464861 Clinical Landscape Report 2026
16 October 2026
NCT06464861 clinical landscape for Mantle-Cell Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dicaprate in Neuroblastoma recurrent: NCT06465199 Clinical Landscape Report 2026
16 October 2026
NCT06465199 clinical landscape for Neuroblastoma recurrent: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mitomycin in Non-Muscle Invasive Bladder Neoplasms: NCT06462001 Clinical Landscape Report 2026
16 October 2026
NCT06462001 clinical landscape for Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Polatuzumab Vedotin-Piiq in Drug-Related Side Effects and Adverse Reactions: NCT06468943 Clinical Landscape Report 2026
16 October 2026
NCT06468943 clinical landscape for Drug-Related Side Effects and Adverse Reactions: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
SNC-103 in Systemic Lupus Erythematosus: NCT06468683 Clinical Landscape Report 2026
16 October 2026
NCT06468683 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.